[CROI 2026] Life4me+: GLP-1 receptor agonists at CROI 2026: Revolution, hype — or the beginning of a new era?

Back to the "HIV and Co-Infections News" list
traffic signs, attention, right of way, a notice, duplicate, question mark, exclamation mark, request, matter, requests, response, task, meaning, expectation, flag, question, ask, information, inform, to learn, solution, man, news, problem, problem solution, mystery, facts, set, sentence construction, difficulty, theme, issue, truth, character, newspaper, future, collaboration, question mark, question mark, question mark, question mark, question, question, question, question, question, problem, problem, facts, facts, facts, facts, future
  • Comorbidities
February 26, 2026
Tags:

Life4me+ news story

At CROI 2026, a conference traditionally focused on antiretroviral therapy, viral persistence and immune activation, one plenary session shifted the spotlight to a different kind of molecule — yet one that may reshape far more than diabetes care. In his lecture, “GLP-1 Receptor Agonists: Are They a Cure for Everything?”, Professor Todd T. Brown of Johns Hopkins University addressed a question that increasingly extends beyond endocrinology:

Are we witnessing a genuine therapeutic revolution — or a moment of medical “irrational exuberance”?

Read the full news story here.

View all Life4me+ reports from CROI 2026

SEE ALSO:

View all AJMC reports from CROI 2026

 

Source : Life4me+

Related HIV and Co-Infections News

See all related HIV and Co-Infections News

Get involved

Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?

Subscribe

Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.